JIM CRAMERNo Business As Usual: Cramer's 'Mad Money' Recap (Thursday 3/12/20)By Scott RuttMar 12, 2020 9:36 PM EDT
PRESS RELEASESChina Gives Greenlight To Allergan's XEN® Registration For The Surgical Management Of Refractory GlaucomaBy PR NewswireApr 2, 2020 7:30 AM EDT
PRESS RELEASESAllergan Earns ENERGY STAR® Partner Of The Year - Sustained Excellence Award For The Seventh Consecutive YearBy PR NewswireMar 31, 2020 10:05 AM EDT
PRESS RELEASESThe Allergan Foundation Donates $2.0 Million To Community Organizations On Front-Line Of COVID-19 ResponseBy PR NewswireMar 30, 2020 9:40 AM EDT
PRESS RELEASESAbbVie And Allergan Sign Consent Decree Agreement With Federal Trade Commission Staff On Pending TransactionBy PR NewswireMar 17, 2020 4:30 PM EDT
JIM CRAMERNo Business As Usual: Cramer's 'Mad Money' Recap (Thursday 3/12/20)By Scott RuttMar 12, 2020 9:36 PM EDT
PRESS RELEASESAllergan Receives FDA Approval For DURYSTA™ (bimatoprost Implant) The First And Only Intracameral Biodegradable Sustained-Release Implant To Lower Intraocular Pressure In Open-Angle Glaucoma Or Ocular Hypertension PatientsBy PR NewswireMar 5, 2020 9:44 AM EST
PRESS RELEASESAbbVie And Allergan Receive Final European Approval To Close Pending TransactionBy PR NewswireMar 3, 2020 8:00 AM EST
PRESS RELEASESBeth Fegan Of FeganScott Law Firm Named Co-Lead Counsel In Allergan BIOCELL Class ActionBy Business WireFeb 19, 2020 12:59 PM EST
PRESS RELEASESINVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Allergan Plc And Encourages Investors With Losses To Contact The FirmBy Business WireFeb 11, 2020 3:59 PM EST
MARKETSNasdaq, S&P 500 Close at Record Highs as Wall Street Assesses Jump in Coronavirus DeathsBy Joseph WoelfelFeb 10, 2020 2:28 PM EST
INVESTINGAllergan Tops Q4 Earnings Forecast, Sees $63 Billion AbbVie Deal Closing in Q1By Martin BaccardaxFeb 10, 2020 9:31 AM EST
MARKETSCoronavirus, Tesla, Victoria's Secret, Allergan and 'Parasite' - 5 Things You Must Know MondayBy Joseph WoelfelFeb 10, 2020 6:11 AM EST
JIM CRAMERKeep an Eye on Earnings: Cramer's 'Mad Money' Recap (Friday 2/7/20)By Scott RuttFeb 7, 2020 8:48 PM EST
JIM CRAMERWhere's the Bear?: Cramer's 'Mad Money' Recap (Thursdsay 1/30/20)By Scott RuttJan 30, 2020 8:56 PM EST
INVESTINGTrading AbbVie as Its Drug Is Seen as Possible Coronavirus TreatmentBy Bret KenwellJan 27, 2020 12:55 PM EST
MARKETSStocks Post Worst Day of Year as Spreading Coronavirus Makes Wall Street JitteryBy Joseph WoelfelJan 27, 2020 2:21 PM EST
MERGERS AND ACQUISITIONSAllergan Sells Drugs to Nestle and AstraZeneca Ahead of AbbVie Tie-UpBy M. Corey GoldmanJan 27, 2020 10:04 AM EST
MARKETSCoronavirus, Dow Futures Plunge, Google and Kobe Bryant - 5 Things You Must Know MondayBy Joseph WoelfelJan 27, 2020 6:18 AM EST
PRESS RELEASESAbbVie And Allergan Announce Agreements To Divest Brazikumab And ZenpepBy PR NewswireJan 27, 2020 1:15 AM EST
PRESS RELEASESSkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible ResultsBy PR NewswireJan 17, 2020 7:30 AM EST
